Therapy-Associated cancerMeSH concept

https://ansm.sante.fr/actualites/retour-dinformation-sur-le-prac-de-juin-2024-10-13-juin
2024
false
false
false
France
French
pharmacovigilance note
risk assessment
risk
dipyrone
agranulocytosis
gene therapy
Chimeric Antigen Receptor T-cells
Antineoplastic Agents, Immunological
Therapy-Associated cancer
Chimeric Antigen Receptor Therapy

---
https://www.cochrane.org/fr/CD011108/SYMPT_lhydromorphone-dans-le-traitement-de-la-douleur-liee-au-cancer
2021
United Kingdom
review of literature
french abstract
pain
hydromorphone
neoplasm, malignant
pain
Therapy-Associated cancer
neoplasms, second primary
Cancer Pain
Cancer
hydromorphone
pain management

---
https://boutique.liguecancer.ch/files/kls/webshop/PDFs/francais/les-douleurs-liees-au-cancer-et-leurs-traitements-021107012111.pdf
2018
Switzerland
patient education handout
pain management
neoplasms, second primary
pain
Cancer Pain
Cancer
Therapy-Associated cancer
neoplasm, malignant

---
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2013/29245a-fra.php
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2013/29249a-fra.php
2013
Canada
French
English
pharmacovigilance note
patient education handout
neoplasms, second primary
Therapy-Associated cancer
risk
thalidomide
thalidomide
multiple myeloma
immunosuppressive agents
leukemia, myeloid, acute
myelodysplastic syndromes
antineoplastic combined chemotherapy protocols

---